• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDKL5 缺乏症中 QI-残疾的心理测量特性:为临床试验做好准备。

Psychometric properties of QI-Disability in CDKL5 Deficiency Disorder: Establishing readiness for clinical trials.

机构信息

Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia.

Children's Hospital Colorado, Pediatric Neurology, University of Colorado, School of Medicine, Aurora, CO, USA.

出版信息

Epilepsy Behav. 2023 Feb;139:109069. doi: 10.1016/j.yebeh.2022.109069. Epub 2023 Jan 10.

DOI:10.1016/j.yebeh.2022.109069
PMID:36634535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9899310/
Abstract

CDKL5 Deficiency Disorder (CDD) is a rare genetic disorder with symptoms of epilepsy, developmental impairments, and other comorbidities. Currently, there are no outcome measures for CDD with comprehensive evidence of validation. This study aimed to evaluate the psychometric properties of the Quality of Life Inventory-Disability (QI-Disability) in CDD. Quality of Life Inventory-Disability was administered to 152 parent caregivers registered with the International CDKL5 Disorder Database (ICDD). Confirmatory factor analysis was conducted and the goodness of fit of the factor structure was assessed. Fixed-effects linear regression models examined the responsiveness of QI-Disability to reported changes in child health. A subset of parent caregivers (n = 56) completed QI-Disability, as well as additional health-related questions, on two occasions separated by four weeks to evaluate test-retest reliability. Test-retest reliability was assessed using intra-class correlations (ICCs) calculated from QI-Disability scores. Based upon adjustments for changes in child health, ICCs were recalculated to estimate responsiveness to change. Confirmatory factor analysis, internal consistency, and divergent validity were mostly satisfactory, except divergent validity was not satisfactory for the Social Interactions and Independence domains. The Physical Health, Social Interactions, Leisure, and Total scores responded to changes in the child's Physical health, and the Negative Emotions and Leisure domains responded to changes in the child's behavior. Unadjusted and adjusted ICC values were above 0.8 for the Positive Emotions, Negative Emotions, Social Interactions, Leisure, Independence domains and Total score, and above 0.6 for the Physical Health domain. Findings suggest that QI-Disability is suitable to assess the quality of life of children and adults with CDD and could be of value for upcoming clinical trials.

摘要

CDKL5 缺乏症(CDD)是一种罕见的遗传性疾病,其症状包括癫痫、发育障碍和其他合并症。目前,尚无针对 CDD 的全面验证的结果测量方法。本研究旨在评估生活质量量表残疾版(QI-Disability)在 CDD 中的心理测量特性。生活质量量表残疾版在国际 CDKL5 疾病数据库(ICDD)注册的 152 名家长照顾者中进行了评估。进行了验证性因子分析,并评估了因子结构的拟合优度。固定效应线性回归模型检验了 QI-Disability 对儿童健康报告变化的反应能力。一组家长照顾者(n=56)在四周的间隔内两次完成了 QI-Disability 以及其他与健康相关的问题,以评估测试-重测信度。使用从 QI-Disability 得分计算的组内相关系数(ICC)评估测试-重测信度。根据儿童健康变化的调整,重新计算 ICC 以估计对变化的反应能力。验证性因子分析、内部一致性和发散效度大多令人满意,除了社会互动和独立性领域的发散效度不令人满意。身体健康、社会互动、休闲和总分对儿童身体健康的变化有反应,消极情绪和休闲领域对儿童行为的变化有反应。未经调整和调整后的 ICC 值在 0.8 以上的有积极情绪、消极情绪、社会互动、休闲、独立领域和总分,在 0.6 以上的有身体健康领域。研究结果表明,QI-Disability 适合评估 CDD 儿童和成人的生活质量,可能对即将进行的临床试验有价值。

相似文献

1
Psychometric properties of QI-Disability in CDKL5 Deficiency Disorder: Establishing readiness for clinical trials.CDKL5 缺乏症中 QI-残疾的心理测量特性:为临床试验做好准备。
Epilepsy Behav. 2023 Feb;139:109069. doi: 10.1016/j.yebeh.2022.109069. Epub 2023 Jan 10.
2
Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.探讨患有严重发育性和癫痫性脑病、CDKL5 缺乏症个体的生活质量。
Epilepsy Res. 2021 Jan;169:106521. doi: 10.1016/j.eplepsyres.2020.106521. Epub 2020 Dec 1.
3
Psychometric evaluation of clinician- and caregiver-reported clinical severity assessments for individuals with CDKL5 deficiency disorder.CDKL5 缺乏症患者的临床医生和照顾者报告的临床严重程度评估的心理测量学评估。
Epilepsia. 2024 Oct;65(10):3064-3075. doi: 10.1111/epi.18094. Epub 2024 Aug 27.
4
Initial Validation and Reliability of the CDKL5 Deficiency Disorder Hand Function Scale (CDD-Hand).CDKL5 缺乏症手功能量表(CDD-Hand)的初步验证和可靠性。
J Child Neurol. 2022 May;37(6):541-547. doi: 10.1177/08830738221091044. Epub 2022 Apr 14.
5
Reliability of the Quality of Life Inventory-Disability Measure in Children with Intellectual Disability.《智障儿童生活质量量表-残疾测量》的可靠性。
J Dev Behav Pediatr. 2020 Sep;41(7):534-539. doi: 10.1097/DBP.0000000000000815.
6
Adapting a measure of gross motor skills for individuals with CDKL5 deficiency disorder: A psychometric study.为患有CDKL5缺陷障碍的个体改编一项粗大运动技能测量方法:一项心理测量学研究。
Epilepsy Res. 2024 Feb;200:107287. doi: 10.1016/j.eplepsyres.2024.107287. Epub 2024 Jan 15.
7
Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric study.用于患有CDKL5缺乏症个体的家长报告睡眠量表的修订:一项心理测量学研究。
J Clin Sleep Med. 2024 Dec 1;20(12):1887-1893. doi: 10.5664/jcsm.11244.
8
A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.了解 CDKL5 缺乏症患者生活质量领域的框架。
Am J Med Genet A. 2019 Feb;179(2):249-256. doi: 10.1002/ajmg.a.61012. Epub 2018 Dec 18.
9
Psychometric properties of the Quality of Life Inventory-Disability (QI-Disability) measure.生活质量量表-残疾(QI-Disability)测量的心理计量学特性。
Qual Life Res. 2019 Mar;28(3):783-794. doi: 10.1007/s11136-018-2057-3. Epub 2018 Nov 20.
10
Communication of individuals with CDKL5 deficiency disorder as observed by caregivers: A descriptive qualitative study.照顾者观察到的 CDKL5 缺乏症患者的沟通:一项描述性定性研究。
Am J Med Genet A. 2024 Jul;194(7):e63570. doi: 10.1002/ajmg.a.63570. Epub 2024 Feb 29.

引用本文的文献

1
What does better look like in individuals with severe neurodevelopmental impairments? A qualitative descriptive study on SCN2A-related developmental and epileptic encephalopathy.严重神经发育障碍个体中“更好”的表现是什么?SCN2A 相关发育性和癫痫性脑病的定性描述性研究。
Qual Life Res. 2024 Feb;33(2):519-528. doi: 10.1007/s11136-023-03543-6. Epub 2023 Dec 8.

本文引用的文献

1
CDKL5 deficiency disorder: clinical features, diagnosis, and management.CDKL5 缺乏症:临床特征、诊断与管理。
Lancet Neurol. 2022 Jun;21(6):563-576. doi: 10.1016/S1474-4422(22)00035-7. Epub 2022 Apr 25.
2
Caregiver assessment of quality of life in individuals with genetic developmental and epileptic encephalopathies.照顾者对遗传性发育性和癫痫性脑病患者生活质量的评估。
Dev Med Child Neurol. 2022 Aug;64(8):957-964. doi: 10.1111/dmcn.15187. Epub 2022 Feb 28.
3
Influences on the trajectory and subsequent outcomes in CDKL5 deficiency disorder.对CDKL5缺乏症的病程及后续结局的影响。
Epilepsia. 2022 Feb;63(2):352-363. doi: 10.1111/epi.17125. Epub 2021 Nov 27.
4
Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder.探讨患有严重发育性和癫痫性脑病、CDKL5 缺乏症个体的生活质量。
Epilepsy Res. 2021 Jan;169:106521. doi: 10.1016/j.eplepsyres.2020.106521. Epub 2020 Dec 1.
5
Reliability of the Quality of Life Inventory-Disability Measure in Children with Intellectual Disability.《智障儿童生活质量量表-残疾测量》的可靠性。
J Dev Behav Pediatr. 2020 Sep;41(7):534-539. doi: 10.1097/DBP.0000000000000815.
6
Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder.基因替换可改善周期蛋白依赖性激酶样 5 障碍的小鼠和人类模型中的缺陷。
Brain. 2020 Mar 1;143(3):811-832. doi: 10.1093/brain/awaa028.
7
Deciphering the concepts behind "Epileptic encephalopathy" and "Developmental and epileptic encephalopathy".解读“癫痫性脑病”和“发育性及癫痫性脑病”背后的概念。
Eur J Paediatr Neurol. 2020 Jan;24:11-14. doi: 10.1016/j.ejpn.2019.12.023. Epub 2019 Dec 31.
8
A framework for understanding quality of life domains in individuals with the CDKL5 deficiency disorder.了解 CDKL5 缺乏症患者生活质量领域的框架。
Am J Med Genet A. 2019 Feb;179(2):249-256. doi: 10.1002/ajmg.a.61012. Epub 2018 Dec 18.
9
Psychometric properties of the Quality of Life Inventory-Disability (QI-Disability) measure.生活质量量表-残疾(QI-Disability)测量的心理计量学特性。
Qual Life Res. 2019 Mar;28(3):783-794. doi: 10.1007/s11136-018-2057-3. Epub 2018 Nov 20.
10
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder.CDKL5 蛋白替代疗法可挽救 CDKL5 障碍小鼠模型的神经表型。
Hum Mol Genet. 2018 May 1;27(9):1572-1592. doi: 10.1093/hmg/ddy064.